Corporate ActionAug 12, 2026, 08:32 AM
ENvue Medical Secures $50M Equity Facility, Amends Series H Deal
AI Summary
ENvue Medical, Inc. entered into a Common Shares Purchase Agreement for a committed equity facility of up to $50 million with an institutional investor. The company can sell common shares at its discretion, with 40% of net proceeds allocated to redeem Series X Preferred Stock. Additionally, the company amended its Series H Purchase Agreement, increasing additional investment rights to $59 million and securing a commitment from the investor to purchase at least $10 million of Series H Preferred Stock over 12 months, subject to shareholder approval.
Key Highlights
- Secured a Committed Equity Facility for up to $50 million in common shares.
- 40% of net proceeds from the facility will redeem Series X Preferred Stock.
- Common shares will be sold at 90% of the lowest 3-day volume-weighted average price (VWAP).
- Amended Series H Purchase Agreement, increasing investment rights to $59 million.
- Investor committed to purchase at least $10 million of Series H Preferred Stock within 12 months.
- Monthly minimum purchase of $833,333.33 for Series H Preferred Stock.
- Series H amendment requires shareholder approval.
- The facility allows the company to sell common shares at its discretion over 36 months.
Price Impact
More from FEED